Search results for " Vasomotor"

showing 4 items of 4 documents

Olfactory function in chronic rhinitis subtypes: Any differences?

2018

Introduction: Olfactory dysfunction is a common problem in rhinological disease, but it has been few evaluated among patients with different chronic rhinitis subtypes. The aim of this study was to assess olfactory function in patients with allergic rhinitis (AR), non-allergic rhinitis (NAR) and mixed rhinitis (MR). Materials and methods: A total of 122 patients with AR, NAR, and MR were included in the study. Sniffin' Sticks test was applied to all groups. The study groups were compared in terms of odor scores and an association between olfactory dysfunction and rhinitis grading, according to ARIA (Allergic Rhinitis and its Impact on Asthma) criteria, was also investigated. Results: A signi…

Olfaction disorders Rhinitis Allergic Rhinitis VasomotorAllergicVasomotorOlfaction disorderRhinitiOlfaction disordersRhinitis
researchProduct

[Psychomotor disadaptation syndrome].

2014

We describe the psychomotor disadaptation syndrome and report the last findings on its physiopathology and therapeutic. This syndrome was first described by Pr Gaudet's team in 1986 and named "psychomotor regression syndrome". This name has been recently changed into "psychomotor disadaptation syndrome".The psychomotor disadaptation syndrome is a decompensation of postural function, gait and psychomotor automatisms due to the alteration of the posture and motor programming. That alteration is linked to subcortical-frontal lesions. Clinically, the psychomotor disadaptation syndrome is characterized by postural impairments (retro-propulsion or backward disequilibrium), non-specific gait disor…

Pediatricsmedicine.medical_specialtyAgingPopulationPosturePoison controlROTTERDAM SCANCEREBRAL VASOMOTOR REACTIVITYDISEASEDiagnosis DifferentialAGEPhysical medicine and rehabilitationPEOPLEmedicineHumansDecompensationeducationELDERLY-PATIENTSPostural BalanceGait Disorders NeurologicPOPULATIONBiological PsychiatryAgedAged 80 and overPsychomotor learningeducation.field_of_studyMovement DisordersHYPERTENSIONABNORMALITIESbusiness.industryfood and beveragesAnhedoniaSyndromeWHITE-MATTER LESIONSPrognosisGaitHyperintensityNeuropsychology and Physiological PsychologySensation DisordersHypertoniaAccidental Falls[ SCCO ] Cognitive scienceNeurology (clinical)Geriatrics and Gerontologymedicine.symptomPsychomotor DisordersbusinessLa Revue de medecine interne
researchProduct

Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders

2019

Insomnia, vasomotor symptoms (VMS) and depression often co-occur after the menopause, with consequent health problems and reductions in quality of life. The aim of this position statement is to provide evidence-based advice on the management of postmenopausal sleep disorders derived from a systematic review of the literature. The latter yielded results on VMS, insomnia, circadian rhythm disorders, obstructive sleep apnea (OSA) and restless leg syndrome (RLS). Overall, the studies show that menopausal hormone therapy (MHT) improves VMS, insomnia, and mood. Several antidepressants can improve insomnia, either on their own or in association with MHT; these include selective serotonin reuptake …

Sleep Initiation and Maintenance Disordermedicine.medical_treatmentSerotonin and Noradrenaline Reuptake InhibitorPosition statementSleep medicine0302 clinical medicineSleep Initiation and Maintenance DisordersCognitive behavioraltherapy for insomnia (CBT-I)InsomniaSleep Wake Disorder030212 general & internal medicineContinuous positive airway pressureRestless legs syndromeSerotonin and Noradrenaline Reuptake InhibitorsCognitive behavioraltherapy for insomnia (CBT-I); Hormonereplacementtherapy (HRT); Menopause; Position statement; Sleepdisorders; Vasomotorsymptoms (VMS)Sleep Apnea Obstructive030219 obstetrics & reproductive medicineContinuous Positive Airway PressureDepressionObstetrics and GynecologySerotonin Uptake InhibitorAntidepressive AgentsMenopauseCognitive behavioral therapyCognitive behavioral therapy for insomnia (CBT-I)SleepdisordersAntidepressive AgentFemalemedicine.symptomMenopauseSelective Serotonin Reuptake Inhibitorsmedicine.drugHumanSleep Wake Disordersmedicine.medical_specialtyHormone Replacement TherapyVasomotor symptoms (VMS)MirtazapineCognitive behavioral therapy for insomnia (CBT-I); Hormone replacement therapy (HRT); Menopause; Position statement; Sleep disorders; Vasomotor symptoms (VMS); Antidepressive Agents; Cognitive Behavioral Therapy; Continuous Positive Airway Pressure; Depression; Exercise; Female; Humans; Mirtazapine; Quality of Life; Restless Legs Syndrome; Serotonin Uptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sleep; Sleep Apnea Obstructive; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Hormone Replacement Therapy; MenopauseMirtazapineSettore MED/10 - Malattie Dell'Apparato RespiratorioHormone replacement therapy (HRT)Hormonereplacementtherapy (HRT)General Biochemistry Genetics and Molecular Biology03 medical and health sciencesRestless Legs Syndromemental disordersmedicineHumansExerciseSleep disorderCognitive Behavioral Therapybusiness.industryVasomotorsymptoms (VMS)medicine.diseasenervous system diseasesObstructive sleep apneaMenopause sleep disorders vasomotor symptoms (VMS) hormone replacement therapy (HRT) Cognitive Behavioral Therapy for Insomnia (CBT-I) Position StatementPhysical therapyQuality of LifebusinessSleep
researchProduct

Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analy…

2019

Background and Objectives: Hot flushes and sleep disturbances are the most common vasomotor symptoms (VMS) reported by postmenopausal women. Hormonal treatment is to date referred to as the gold standard approach but not suitable for all the patients. Alternative treatments are needed in case of a contraindication to menopausal hormone therapy (MHT), adverse side effects, and poor compliance. Paroxetine salt is the only nonhormonal medication approved by the US Food and Drug Administration for the management of VMS. Nonetheless, few trials with low consensus are available about this topic. In this review, we aimed to evaluate the efficacy of low-dose paroxetine therapy in the treatment of v…

Sleep Wake Disordersmedicine.medical_specialtyMedicine (General)Ovariectomyvasomotor symptomsefficacymenopauseReviewPlacebosleep disturbanceslaw.inventionR5-920Randomized controlled triallawInternal medicinemedicineHumanshot flusheAdverse effectContraindicationRandomized Controlled Trials as TopicVasomotorbusiness.industryGeneral Medicinemedicine.diseasesleep disturbanceParoxetineMenopausePostmenopauseParoxetineMeta-analysisefficacy; hot flushes; menopause; paroxetine; sleep disturbances; vasomotor symptomsHot FlashesFemalehot flushesbusinessSelective Serotonin Reuptake Inhibitorsmedicine.drugMedicina
researchProduct